Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab-induced coagulopathy.
Novak J, Mocikova H, Pavlicek P, Gaherova L, Kozak T. Novak J, et al. Among authors: kozak t. Leuk Lymphoma. 2012 Nov;53(11):2299-301. doi: 10.3109/10428194.2012.682313. Epub 2012 May 16. Leuk Lymphoma. 2012. PMID: 22480246 Review. No abstract available.
Clinical case: idelalisib-induced immunoglobulin flare.
Novak J, Havrda M, Gaherova L, Spicka J, Kozak T. Novak J, et al. Among authors: kozak t. Immunopharmacol Immunotoxicol. 2017 Aug;39(4):251-252. doi: 10.1080/08923973.2017.1318912. Epub 2017 May 19. Immunopharmacol Immunotoxicol. 2017. PMID: 28523957
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
Markova J, Kahraman D, Kobe C, Skopalova M, Mocikova H, Klaskova K, Dedeckova K, Eich HT, Böll B, Dietlein M, Kozak T. Markova J, et al. Among authors: kozak t. Leuk Lymphoma. 2012 Jan;53(1):64-70. doi: 10.3109/10428194.2011.603444. Epub 2011 Aug 24. Leuk Lymphoma. 2012. PMID: 21740300
Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.
Procházka V, Papajík T, Janíková A, Belada D, Kozák T, Šálek D, Sýkorová A, Móciková H, Campr V, Dlouhá J, Langová K, Fürst T, Trněný M. Procházka V, et al. Among authors: kozak t. Leuk Lymphoma. 2017 Mar;58(3):601-613. doi: 10.1080/10428194.2016.1213834. Epub 2016 Sep 25. Leuk Lymphoma. 2017. PMID: 27666539
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group.
Smolej L, Brychtová Y, Cmunt E, Doubek M, Špaček M, Belada D, Šimkovič M, Stejskal L, Zygulová I, Urbanová R, Brejcha M, Zuchnická J, Móciková H, Kozák T; Czech CLL Study Group. Smolej L, et al. Among authors: kozak t. Br J Haematol. 2021 May;193(4):769-778. doi: 10.1111/bjh.17373. Epub 2021 Feb 22. Br J Haematol. 2021. PMID: 33618437 Clinical Trial.
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.
Pytlík R, Belada D, Kubáčková K, Vášová I, Kozák T, Pirnos J, Bolomská I, Matuška M, Přibylová J, Campr V, Burešová L, Sýkorová A, Berková A, Klener P, Trněný M; Czech Lymphoma Study Group. Pytlík R, et al. Among authors: kozak t. Leuk Lymphoma. 2015 Jan;56(1):57-64. doi: 10.3109/10428194.2014.904509. Epub 2014 Apr 29. Leuk Lymphoma. 2015. PMID: 24628294
137 results